Works matching DE "IPILIMUMAB"


Results: 2529
    1

    Response to Letter to the Editor From Zhang et al: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer".

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 7, p. e2425, doi. 10.1210/clinem/dgaf221
    By:
    • Konda, Bhavana;
    • Sherman, Eric J;
    • Massarelli, Erminia;
    • Nieva, Jorge;
    • Muzaffar, Jameel;
    • Morris, John C;
    • Ryder, Mabel;
    • Ho, Alan L;
    • Agulnik, Mark;
    • Wei, Lai;
    • Handley, Demond;
    • Moses, Catherine;
    • Jacob, Rajani;
    • Wright, John;
    • Streicher, Howard;
    • Carson, William;
    • Shah, Manisha H
    Publication type:
    Article
    2
    3
    5

    Administration of nivolumab plus ipilimumab: Infusion of the fixed‐ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800).

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 14, p. 1, doi. 10.1002/cncr.35962
    By:
    • Menzies, Alexander M.;
    • Salman, Pamela;
    • Frontera, Osvaldo Arén;
    • Pook, David;
    • Hocking, Christopher M.;
    • Zakharia, Yousef;
    • Gurney, Howard;
    • Gedye, Craig;
    • Goh, Jeffrey C.;
    • Telivala, Bijoy;
    • Grob, Jean‐Jacques;
    • Lebbé, Céleste;
    • de la Cruz Merino, Luis;
    • Machet, Laurent;
    • Neidhardt, Eve‐Marie;
    • Qureshi, Anila;
    • Hosein, Fareeda;
    • Hamuro, Lora;
    • Simsek, Burcin;
    • Amin, Asim
    Publication type:
    Article
    6
    7

    Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

    Published in:
    British Journal of Surgery, 2025, v. 112, n. 6, p. 1, doi. 10.1093/bjs/znaf090
    By:
    • Tas, Liselotte;
    • Weitemeyer, Marie B;
    • Rohaan, Maartje W;
    • Borch, Troels H;
    • van Akkooi, Alexander C J;
    • Wouters, Michel W J M;
    • Hartemink, Koen J;
    • Schrage, Yvonne M;
    • Kuijpers, Anke;
    • Kok, Niels F M;
    • van Zon, Maaike;
    • Jedema, Inge;
    • Nijenhuis, Cynthia M;
    • Nuijen, Bastiaan;
    • Hansen, Marten;
    • Voermans, Carlijn;
    • Klobuch, Sebastian;
    • Seijkens, Tom T P;
    • Lalezari, Ferry;
    • Met, Özcan
    Publication type:
    Article
    8
    9

    The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 146, n. 1, p. 181, doi. 10.1007/s11060-019-03363-0
    By:
    • Martins, Filipe;
    • Schiappacasse, Luis;
    • Levivier, Marc;
    • Tuleasca, Constantin;
    • Cuendet, Michel A.;
    • Aedo-Lopez, Veronica;
    • Gautron Moura, Bianca;
    • Homicsko, Krisztian;
    • Bettini, Adrienne;
    • Berthod, Gregoire;
    • Gérard, Camille L.;
    • Wicky, Alexandre;
    • Bourhis, Jean;
    • Michielin, Olivier
    Publication type:
    Article
    10
    11
    12

    Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 140, n. 1, p. 173, doi. 10.1007/s11060-018-2948-8
    By:
    • Furtner, Julia;
    • Berghoff, Anna S.;
    • Schöpf, Veronika;
    • Reumann, Robert;
    • Pascher, Benjamin;
    • Woitek, Ramona;
    • Asenbaum, Ulrika;
    • Pelster, Sebastian;
    • Leitner, Johannes;
    • Widhalm, Georg;
    • Gatterbauer, Brigitte;
    • Dieckmann, Karin;
    • Höller, Christoph;
    • Prayer, Daniela;
    • Preusser, Matthias
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.

    Published in:
    Journal of Neuro-Oncology, 2014, v. 118, n. 1, p. 109, doi. 10.1007/s11060-014-1400-y
    By:
    • Queirolo, Paola;
    • Spagnolo, Francesco;
    • Ascierto, Paolo;
    • Simeone, Ester;
    • Marchetti, Paolo;
    • Scoppola, Alessandro;
    • Vecchio, Michele;
    • Guardo, Lorenza;
    • Maio, Michele;
    • Giacomo, Anna;
    • Antonuzzo, Andrea;
    • Cognetti, Francesco;
    • Ferraresi, Virginia;
    • Ridolfi, Laura;
    • Guidoboni, Massimo;
    • Guida, Michele;
    • Pigozzo, Jacopo;
    • Chiarion Sileni, Vanna
    Publication type:
    Article
    19
    20
    21
    22

    Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250
    By:
    • LaPelusa, Michael;
    • Chamseddine, Shadi;
    • Tran Cao, Hop Sanderson;
    • Xiao, Lianchun;
    • Hasanov, Elshad;
    • Bhosale, Priya;
    • Amin, Hesham M.;
    • Mohamed, Yehia I.;
    • Gok Yavuz, Betul;
    • Sakr, Yara;
    • Xu, Li;
    • Hu, Ian;
    • Lee, Sunyoung S.;
    • Sakamuri, Divya;
    • Jindal, Sonali;
    • Nguyen, Van;
    • Curran, Michael A.;
    • Sun, Ryan;
    • Rashid, Asif;
    • Duda, Dan Gabriel
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Treatment of Brain Metastases.

    Published in:
    Oncology, 2014, v. 87, n. 6, p. 321, doi. 10.1159/000362389
    By:
    • Lukas, Rimas V.;
    • Gabikian, Patrik;
    • Garza, Madeline;
    • Chmura, Steven J.
    Publication type:
    Article
    29
    30
    31

    Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 3, p. e210980, doi. 10.1001/jamanetworkopen.2021.0980
    By:
    • Waninger, Jessica J.;
    • Ma, Vincent T.;
    • Journey, Sara;
    • Skvarce, Jeremy;
    • Chopra, Zoey;
    • Tezel, Alangoya;
    • Bryant, Alex K.;
    • Mayo, Charles;
    • Sun, Yilun;
    • Sankar, Kamya;
    • Ramnath, Nithya;
    • Lao, Christopher;
    • Sussman, Jeremy B.;
    • Fecher, Leslie;
    • Alva, Ajjai;
    • Green, Michael D.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Immune Checkpoint Inhibitors' Associated Renal Toxicity: A Series of 12 Cases.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 16, p. 4786, doi. 10.3390/jcm11164786
    By:
    • Palamaris, Kostas;
    • Alexandris, Dimitrios;
    • Stylianou, Kostas;
    • Giatras, Ioannis;
    • Stofas, Anastasios;
    • Kaitatzoglou, Christina;
    • Migkou, Magda;
    • Goutas, Dimitrios;
    • Psimenou, Erasmia;
    • Theodoropoulou, Eleni;
    • Theocharis, Stamatios;
    • Alevizopoulos, Nektarios;
    • Kastritis, Efstathios;
    • Gerakis, Alexandros;
    • Gakiopoulou, Harikleia
    Publication type:
    Article
    45
    46
    47
    48

    Checkpoint Inhibitors and the Gut.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 824, doi. 10.3390/jcm11030824
    By:
    • Tran, Tuan;
    • Tran, Nguyen Giang Tien;
    • Ho, Vincent
    Publication type:
    Article
    49
    50